STAT July 11, 2024
Why are pharmaceutical companies cutting more staff than cash-strapped biotechs? And who will Pfizer scout out as its next science chief?
STAT’s West Coast biotech reporter Jonathan Wosen joins “The Readout LOUD” to discuss what’s driving workforce cuts.
We also discuss a big change in Pfizer’s leadership and the debate over a new side effect tied to the diabetes drug Ozempic. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotech incubator Curie.Bio and how they hope...